Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 Protagonist TherapeuticsAlbireo PharmaMirum PharmaceuticalsTheratechnologiesBIOFRONTERA AG/ADR
SymbolNASDAQ:PTGXNASDAQ:ALBONASDAQ:MIRMOTCMKTS:THERFNASDAQ:BFRA
Price Information
Current Price$14.58$25.45$9.36$4.2361$14.00
52 Week RangeBuyBuyBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$21.50$60.3333$25.00N/A$17.00
% Upside from Price Target47.46% upside137.07% upside167.09% upsideN/A21.43% upside
Trade Information
Market Cap$389.47 million$316.88 million$215.19 million$342.43 million$310.64 million
Beta1.731.53N/A0.590.91
Average Volume204,20250,53259,79546,4143,570
Sales & Book Value
Annual Revenue$30.92 million$12.74 millionN/A$45.18 million$24.93 million
Price / Sales12.3925.34N/A7.2212.53
CashflowN/AN/AN/A$0.0202 per shareN/A
Price / CashN/AN/AN/A209.76N/A
Book Value$4.65 per share$10.24 per shareN/A$0.47 per share$0.87 per share
Price / Book3.142.49N/A9.0116.09
Profitability
Net Income$-38,920,000.00$-46,110,000.00N/A$-4,660,000.00$-10,480,000.00
EPS($1.74)($3.94)N/AN/AN/A
Trailing P/E RatioN/AN/A0.000.00464.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-209.02%-2,403.88%N/A-8.78%4.48%
Return on Equity (ROE)-62.50%-51.74%N/A-4.97%8.02%
Return on Assets (ROA)-46.34%-34.40%N/A-1.52%3.02%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/AN/A1.70%1.56%
Current Ratio4.12%13.83%7.64%2.69%3.84%
Quick Ratio4.12%13.83%7.64%2.19%3.38%
Ownership Information
Institutional Ownership Percentage73.41%73.02%N/A1.37%0.01%
Insider Ownership Percentage14.20%3.70%N/AN/AN/A
Miscellaneous
Employees64392032149
Shares Outstanding26.28 million12.69 million22.99 million76.95 million22.32 million
Next Earnings Date11/5/2019 (Estimated)11/12/2019 (Estimated)11/27/2019 (Estimated)10/3/2019 (Estimated)11/15/2019 (Estimated)
OptionableNot OptionableOptionableNot OptionableNot OptionableNot Optionable
 Protagonist TherapeuticsAlbireo PharmaMirum PharmaceuticalsTheratechnologiesBIOFRONTERA AG/ADR

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel